Disclaimer:

Anti-Aging & Weight Loss Center is NOT prescribing the Brand name Semaglutide or Tirzepatide BUT we are prescribing the compounded Semaglutide/Tirzepatide injection which is an injectable prescription medicine used for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems to help them lose weight.

• Semaglutide/Tirzepatide should be used with a reduced calorie meal plan and increased physical activity.
• Semaglutide contains Semaglutide and should NOT be used with other Semaglutide-containing products or other GLP-1 receptor agonist medicines.
• Tirzepatide contains Tirzepatide and should NOT be used with other Tirzepatide-containing products or other GLP-1 receptor agonist medicines.
• It is not known if Semaglutide/Tirzepatide is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products.
• It is not known if Semaglutide/Tirzepatide can be used safely in people with a history of pancreatitis.
• It is not known if Semaglutide/Tirzepatide is safe and effective for use in children under 18 years of age.

 

Semaglutide/Tirzepatide may cause serious side effects, including:

• Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Semaglutide and medicines that work like Semaglutide caused thyroid tumors, including thyroid cancer. It is not known if Semaglutide will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

 

Do NOT use Semaglutide/Tirzepatide if: 

• You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• You have had a serious allergic reaction to Semaglutide or any of the ingredients in Semaglutide.

 

Before using Semaglutide/Tirzepatide, tell your healthcare provider if you have any other medical conditions, including if you:

• have or have had problems with your pancreas or kidneys.
• have history of diabetic retinopathy.
• have or have had depression, suicidal thoughts, or mental health issues.
• are pregnant or plan to become pregnant. Semaglutide/Tirzepatide may harm your unborn baby. You should stop using Semaglutide 2 months before you plan to become pregnant.
• are breastfeeding or plan to breastfeed. It is not known if Semaglutide/Tirzepatide passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the- counter medicines, vitamins, and herbal supplements. Semaglutide or Tirzepatide may affect the way some medicines work and some medicines may affect the way Semaglutide/Tirzepatide works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including Sulfonylureas or insulin. Semaglutide/Tirzepatide slows stomach emptying and can affect medicines that need to pass through the stomach quickly.

 

Semaglutide/Tirzepatide may cause serious side effects, including:

• inflammation of your pancreas (pancreatitis). Stop using Semaglutide or Tirzepatide and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
• gallbladder problems. Semaglutide/Tirzepatide may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools.
• increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin. This can be both a serious and common side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Semaglutide. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery.
• kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
• serious allergic reactions. Stop using Semaglutide/Tirzepatide and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
• change in vision in patients with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Semaglutide or Tirzepatide.
• increased heart rate. Semaglutide can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes.
• depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse or worry you.

 

The most common side effects of Semaglutide/Tirzepatide may include nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu and heartburn.

It’s recommended to take medication once-weekly on the same day each week at any time of day.

Do not share your Semaglutide/Tirzepatide injections with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.

 

Consent to treatment by a physician extender: You may be evaluated and treated by a physician assistant (P.A.) or a nurse practitioner (N.P.) whose recommended care and treatment is subject to supervision and review by a licensed physician.
 

 
I HAVE READ AND FULLY UNDERSTAND THIS CONSENT FORM AND I REALIZE I SHOULD NOT SIGN THIS FORM IF ALL ITEMS HAVE NOT BEEN SATISFACTORY EXPLAINED TO ME. WITH MY SIGNATURE, I ACKNOWLEDGE THAT MY QUESTIONS HAVE BEEN ANSWERED FULLY, AND THAT I HAVE BEEN REQUESTED TO READ THIS FORM AND HAVE BEEN GIVEN AMPLE TIME TO UNDERSTAND ALL ITS CONTENTS.